GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M1 Kliniken AG (XTER:M12) » Definitions » Stock Based Compensation

M1 Kliniken AG (XTER:M12) Stock Based Compensation : €0.0 Mil (TTM As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is M1 Kliniken AG Stock Based Compensation?

M1 Kliniken AG's Stock Based Compensation for the six months ended in Jun. 2023 was €0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was €0.0 Mil.

M1 Kliniken AG Stock Based Compensation Historical Data

The historical data trend for M1 Kliniken AG's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M1 Kliniken AG Stock Based Compensation Chart

M1 Kliniken AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only - - - - -

M1 Kliniken AG Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

M1 Kliniken AG Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

M1 Kliniken AG Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of M1 Kliniken AG's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

M1 Kliniken AG (XTER:M12) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M1 Kliniken AG (XTER:M12) » Definitions » Stock Based Compensation
Comparable Companies
XTER:MED XTER:MAK XTER:V3V FRA:EIF XTER:RHK HCA SZSE:300015 SAU:4013 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS CHE NSE:APOLLOHOSP AGL ASX:RHC DVA
Traded in Other Exchanges
M12:Germany M12:Germany M12:Germany
Address
Grunauer strasse 5, Berlin, BB, DEU, 12557
Website
https://www.m1-kliniken.de
M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.
Executives
Kilian Brenske Board of Directors
Attila Strauss Board of Directors

M1 Kliniken AG (XTER:M12) Headlines

No Headlines